Published in PLoS One on May 19, 2011
Fish oil has beneficial effects on allergen-induced airway inflammation and hyperreactivity in mice. PLoS One (2013) 0.89
Exogenous interleukin-10 alleviates allergic inflammation but inhibits local interleukin-10 expression in a mouse allergic rhinitis model. BMC Immunol (2014) 0.82
Precursor B Cells Increase in the Lung during Airway Allergic Inflammation: A Role for B Cell-Activating Factor. PLoS One (2016) 0.77
Roles of histone hypoacetylation in LAT expression on T cells and Th2 polarization in allergic asthma. J Transl Med (2013) 0.75
Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 40.32
The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell (2006) 33.94
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol (1995) 29.42
A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell (2000) 17.61
The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell (1997) 12.68
Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity (2009) 9.28
Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol (2007) 6.80
Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature (2007) 6.58
IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol (2008) 6.41
Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol (1999) 6.15
The global burden of asthma. Chest (2006) 5.74
Helper T cell differentiation is controlled by the cell cycle. Immunity (1998) 5.71
Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest (2009) 4.10
Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat Immunol (2008) 3.88
Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J Exp Med (1993) 3.10
CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations. J Immunol (2000) 2.98
The IL-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol (1993) 2.96
Activation-induced cell death in T cells. Immunol Rev (2003) 2.82
GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol (2007) 2.49
Tr1 cells: from discovery to their clinical application. Semin Immunol (2006) 2.05
T-cell responses to allergens. J Allergy Clin Immunol (2007) 1.97
The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients. J Exp Med (1996) 1.89
Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro. Int J Cancer (2007) 1.85
Role of Treg in immune regulation of allergic diseases. Eur J Immunol (2010) 1.82
T cell trafficking in allergic asthma: the ins and outs. Annu Rev Immunol (2008) 1.76
Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells. Nat Immunol (2011) 1.66
CD4+CD25+ T cell depletion impairs tolerance induction in a murine model of asthma. Clin Exp Allergy (2009) 1.61
Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice. J Clin Invest (2009) 1.52
IL-2Rbeta links IL-2R signaling with Foxp3 expression. Eur J Immunol (2007) 1.52
Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells. J Immunol (2006) 1.52
Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells. J Immunol (2002) 1.51
Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. J Immunol (2007) 1.39
Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo. J Exp Med (2007) 1.08
Osteopontin expression and relation to disease severity in human asthma. Eur Respir J (2010) 1.02
Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells. Endocrinology (2010) 1.00
Effects of pollen and nasal glucocorticoid on FOXP3+, GATA-3+ and T-bet+ cells in allergic rhinitis. Allergy (2007) 0.99
IL-9 promotes but is not necessary for systemic anaphylaxis. J Immunol (2005) 0.96
Targeting chemokine receptors in allergic disease. Biochem J (2011) 0.95
Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation. PLoS One (2009) 0.95
Mechanisms of T cell migration to the lung. Clin Exp Allergy (2005) 0.94
Human bronchial epithelium controls TH2 responses by TH1-induced, nitric oxide-mediated STAT5 dephosphorylation: implications for the pathogenesis of asthma. J Immunol (2005) 0.90
CD25 appears non essential for human peripheral T(reg) maintenance in vivo. PLoS One (2010) 0.86
Comparative analysis of the early transcriptome of Brucella abortus--infected monocyte-derived macrophages from cattle naturally resistant or susceptible to brucellosis. Res Vet Sci (2010) 0.83
Local proliferation and mobilization of CCR3(+) CD34(+) eosinophil-lineage-committed cells in the lung. Immunology (2010) 0.83
Role of CCL21 and CCL19 in allergic inflammation in the ovalbumin-specific murine asthmatic model. J Allergy Clin Immunol (2006) 0.82
Prolonged eosinophil production after allergen exposure in IFN-gammaR KO mice is IL-5 dependent. Scand J Immunol (2008) 0.81
Th17 and treg cells innovate the TH1/TH2 concept and allergy research. Chem Immunol Allergy (2008) 0.80
New production of eosinophils and the corresponding TH1/TH2 balance in the lungs after allergen exposure in BALB/c and C57BL/6 mice. Scand J Immunol (2010) 0.77
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles (2013) 4.05
Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol (2012) 3.18
Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med (2011) 3.03
Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Am J Respir Crit Care Med (2010) 2.56
Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol (2003) 2.50
Large scale questionnaire survey on respiratory health in Sweden: effects of late- and non-response. Respir Med (2009) 2.22
Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med (2002) 2.21
Isolation and characterization of RNA-containing exosomes. J Vis Exp (2012) 2.16
Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles (2013) 2.08
Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids. Ann Allergy Asthma Immunol (2012) 1.97
Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PLoS One (2010) 1.94
Rhinovirus viremia in children with respiratory infections. Am J Respir Crit Care Med (2005) 1.78
Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol (2002) 1.63
Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial. Respir Med (2012) 1.57
Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells. J Extracell Vesicles (2012) 1.52
Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods. Mol Immunol (2012) 1.52
Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. Am J Respir Cell Mol Biol (2005) 1.48
Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. Eur J Pharmacol (2003) 1.45
The influence of personality traits and beliefs about medicines on adherence to asthma treatment. Prim Care Respir J (2011) 1.38
EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles. J Extracell Vesicles (2013) 1.34
The multiple roles of phosphoinositide 3-kinase in mast cell biology. Trends Immunol (2008) 1.27
Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease. Expert Opin Investig Drugs (2005) 1.26
Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano (2013) 1.23
Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma. Eur Respir J (2013) 1.20
Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD. Respir Res (2007) 1.16
Past, present and future--beta2-adrenoceptor agonists in asthma management. Respir Med (2005) 1.13
Human Metapneumovirus as a causative agent of acute bronchiolitis in infants. J Clin Virol (2004) 1.12
Functional relevance of the IL-23-IL-17 axis in lungs in vivo. Am J Respir Cell Mol Biol (2006) 1.09
Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone. Thorax (2013) 1.08
Increased prevalence of symptoms of rhinitis but not of asthma between 1990 and 2008 in Swedish adults: comparisons of the ECRHS and GA²LEN surveys. PLoS One (2011) 1.05
The influence of personality traits on reported adherence to medication in individuals with chronic disease: an epidemiological study in West Sweden. PLoS One (2011) 1.04
EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy. Clin Transl Allergy (2012) 1.04
Eosinophil progenitors in allergy and asthma - do they matter? Pharmacol Ther (2008) 1.04
Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma. Respir Res (2011) 1.02
Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy (2007) 1.01
Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses. J Immunol (2013) 1.00
Btk-dependent Rac activation and actin rearrangement following FcepsilonRI aggregation promotes enhanced chemotactic responses of mast cells. J Cell Sci (2010) 0.99
Does respiratory syncytial virus subtype influences the severity of acute bronchiolitis in hospitalized infants? Respir Med (2004) 0.98
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
Duration of postviral airway hyperresponsiveness in children with asthma: effect of atopy. J Allergy Clin Immunol (2005) 0.97
Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial. Respir Res (2011) 0.95
Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study. BMC Pulm Med (2014) 0.95
IL-17-producing T lymphocytes in lung tissue and in the bronchoalveolar space after exposure to endotoxin from Escherichia coli in vivo--effects of anti-inflammatory pharmacotherapy. Pulm Pharmacol Ther (2008) 0.94
RNA-containing exosomes in human nasal secretions. Am J Rhinol Allergy (2010) 0.94
Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses. J Allergy Clin Immunol (2006) 0.94
Adult-onset asthma in west Sweden--incidence, sex differences and impact of occupational exposures. Respir Med (2011) 0.93
Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells--Evidence of unique microRNA cargos. RNA Biol (2015) 0.93
Eotaxin-2 regulates newly produced and CD34 airway eosinophils after allergen exposure. J Allergy Clin Immunol (2004) 0.91
Asthma in late adolescence--farm childhood is protective and the prevalence increase has levelled off. Pediatr Allergy Immunol (2010) 0.90
Prevalence of chronic nasal symptoms in West Sweden: risk factors and relation to self-reported allergic rhinitis and lower respiratory symptoms. Int Arch Allergy Immunol (2010) 0.88
Mast cell exosomes promote lung adenocarcinoma cell proliferation - role of KIT-stem cell factor signaling. Cell Commun Signal (2014) 0.88
Levalbuterol has not been established to have therapeutic advantage over racemic albuterol. J Allergy Clin Immunol (2002) 0.87
Rhinitis phenotypes correlate with different symptom presentation and risk factor patterns of asthma. Respir Med (2011) 0.87
Questionnaire layout and wording influence prevalence and risk estimates of respiratory symptoms in a population cohort. Clin Respir J (2012) 0.86
Effects of the antifungal imidazole ketoconazole on CYP1A and CYP3A in rainbow trout and killifish. Environ Toxicol Chem (2004) 0.85
Regulation of bone marrow and airway CD34+ eosinophils by interleukin-5. Am J Respir Cell Mol Biol (2003) 0.85
Airway allergen exposure stimulates bone marrow eosinophilia partly via IL-9. Respir Res (2005) 0.85
Proteomics in asthma and COPD phenotypes and endotypes for biomarker discovery and improved understanding of disease entities. J Proteomics (2011) 0.84
Respiratory symptoms and respiratory-related absence from work among health care workers in Sweden. J Asthma (2013) 0.84
GATA transcription factors regulate the expression of the human eosinophil-derived neurotoxin (RNase 2) gene. J Biol Chem (2009) 0.84
Interleukin-6 in preterm premature rupture of membranes as an indicator of neonatal outcome. Acta Obstet Gynecol Scand (2005) 0.84
Allergen exposure-induced differences in CD34+ cell phenotype: relationship to eosinophilopoietic responses in different compartments. Blood (2003) 0.84
The function of medication beliefs as mediators between personality traits and adherence behavior in people with asthma. Patient Prefer Adherence (2013) 0.84
Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma. Ther Adv Respir Dis (2013) 0.83
Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial. Respir Res (2014) 0.83
Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD. J Clin Pharmacol (2008) 0.83
Recent educational interventions for improvement of asthma medication adherence. Asia Pac Allergy (2012) 0.83
Allergen-induced traffic of bone marrow eosinophils, neutrophils and lymphocytes to airways. Eur J Immunol (2004) 0.83
Local proliferation and mobilization of CCR3(+) CD34(+) eosinophil-lineage-committed cells in the lung. Immunology (2010) 0.83
MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma. BMC Cancer (2014) 0.83